ATP-柠檬酸裂解酶 (ACLY) 是一种中心代谢酶,可催化 ATP 依赖的柠檬酸和辅酶 A (CoA) 转化为草酰乙酸和乙酰辅酶 A。乙酰辅酶 A 产物对脂肪酸代谢、胆固醇生物合成以及蛋白质乙酰化和异戊烯化至关重要。乙酰辅酶 A 也是修饰蛋白质的乙酰化反应所必需的,例如组蛋白乙酰化。ACLY 在几种类型的癌症中上调或激活,已知其抑制可在体外和体内诱导癌细胞增殖停滞。
ACLY 通过在 ATP 和 CoA 存在下催化糖酵解产生的柠檬酸形成乙酰辅酶 A 和草酰乙酸,将葡萄糖和脂质代谢联系起来。ACLY 在许多永生化细胞和肿瘤中异常表达,例如乳腺癌、肝癌、结肠癌、肺癌和前列腺癌,并且与肿瘤分期和分化呈负相关,可作为负面预后标志物。ACLY 是长链脂肪酸合成的上游酶,提供乙酰辅酶 A 作为脂肪酸合成的必需成分。因此,ACLY 是细胞脂肪生成的关键酶和癌症治疗的有力靶点。
ATP-citrate lyase (ACLY) is a central metabolic enzyme and catalyses the ATP-dependent conversion of citrate and coenzyme A (CoA) to oxaloacetate and acetyl-CoA. The acetyl-CoA product is crucial for the metabolism of fatty acids, the biosynthesis of cholesterol, and the acetylation and prenylation of proteins. Acetyl CoA is also required for acetylation reactions that modify proteins, such as histone acetylation. ACLY is upregulated or activated in several types of cancers, and its inhibition is known to induce proliferation arrest in cancer cells both in vitro and in vivo.
ACLY links glucose and lipid metabolism by catalyzing the formation of acetyl-CoA and oxaloacetate from citrate produced by glycolysis in the presence of ATP and CoA. ACLY is aberrantly expressed in many immortalized cells and tumors, such as breast, liver, colon, lung and prostate cancers, and is correlated reversely with tumor stage and differentiation, serving as a negative prognostic marker. ACLY is an upstream enzyme of the long chain fatty acid synthesis, providing acetyl-CoA as an essential component of the fatty acid synthesis. Therefore, ACLY is a key enzyme of cellular lipogenesis and potent target for cancer therapy.
Hydroxycitric acid 是一种口服有效的多靶点、多生物活性有机酸,可激活 Nrf2 和下游分子 GPX4 以提升谷胱甘肽水平,从而抑制铁死亡 (ferroptosis),并通过激活 Nrf2/Keap1 和 ACLY/NF-κB 信号通路、上调超氧化物歧化酶等抗氧化酶活性、降低 MDA 含量,减轻氧化应激和肾小管上皮细胞凋亡 (apoptosis),改善肺血管和右心室重构,同时还能激活 AMPK 和 mTORC1/S6K 通路,触发未折叠蛋白反应,阻滞癌细胞周期并引起 DNA 片段化。
Hydroxycitric acid tripotassium 是一种口服有效的多靶点、多生物活性有机酸,可激活 Nrf2 和下游分子 GPX4 并提升谷胱甘肽水平,从而抑制铁死亡 (ferroptosis),同时通过激活 Nrf2/Keap1 和 ACLY/NF-κB 信号通路、上调超氧化物歧化酶等抗氧化酶活性并降低 MDA 含量,减轻氧化应激和肾小管上皮细胞凋亡 (apoptosis),改善肺血管和右心室重构,还能同时激活 AMPK 和 mTORC1/S6K 通路,触发未折叠蛋白反应,阻滞癌细胞周期并引起 DNA 片段化。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号